Prognostic markers for CAR-T cell therapy in patients with relapsed/refractory multiple myeloma

被引：0
|
作者：
Liu, Yang [1 ]
Yan, Zhiling [2 ]
Wu, Qingyun [2 ]
Chen, Chong [2 ]
Cao, Jiang [2 ]
Li, Zhenyu [2 ]
Xu, Kailin [2 ]
机构：
[1] Xuzhou Med Univ, Dept Hematol, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Blood Dis Inst, Xuzhou, Jiangsu, Peoples R China
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-029
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [41] The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma
    Rejeski, Kai
    Hansen, Doris K.
    Bansal, Radhika
    Sesques, Pierre
    Ailawadhi, Sikander
    Logue, Jennifer M.
    Braeunlein, Eva
    dos Santos, David M. Cordas M.
    Freeman, Ciara L.
    Alsina, Melissa
    Theurich, Sebastian
    Wang, Yucai
    Krackhardt, Angela M.
    Locke, Frederick L.
    Bachy, Emmanuel
    Jain, Michael D.
    Lin, Yi
    Subklewe, Marion
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [42] Impact of Frailty on Outcomes after CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma
    Davis, James A.
    Dima, Danai
    Ahmed, Nausheen
    DeJarnette, Shaun
    McGuirk, Joseph P.
    Khouri, Jack
    Valent, Jason
    Anwer, Faiz
    Abdallah, Al-Ola
    Hashmi, Hamza
    BLOOD, 2023, 142
  • [43] Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy
    Kambhampati, Swetha
    Sheng, Ying
    Huang, Chiung-Yu
    Bylsma, Sophia
    Lo, Mimi
    Kennedy, Vanessa
    Natsuhara, Kelsey
    Martin, Thomas
    Wolf, Jeffrey
    Shah, Nina
    Wong, Sandy W.
    BLOOD ADVANCES, 2022, 6 (07) : 2045 - 2054
  • [44] The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma
    Kai Rejeski
    Doris K. Hansen
    Radhika Bansal
    Pierre Sesques
    Sikander Ailawadhi
    Jennifer M. Logue
    Eva Bräunlein
    David M. Cordas dos Santos
    Ciara L. Freeman
    Melissa Alsina
    Sebastian Theurich
    Yucai Wang
    Angela M. Krackhardt
    Frederick L. Locke
    Emmanuel Bachy
    Michael D. Jain
    Yi Lin
    Marion Subklewe
    Journal of Hematology & Oncology, 16
  • [45] BCMA CAR-T Therapy Is Safe and Effective for Refractory/Relapsed Multiple Myeloma With Central Nervous System Involvement
    Wang, Yiyun
    Zu, Cheng
    Teng, Xinyi
    Yang, Li
    Zhang, Mingming
    Hong, Ruimin
    Zhao, Houli
    Cui, Jiazhen
    Xu, Huijun
    Hongsheng, Alex Chang
    Hu, Yongxian
    Huang, He
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (01) : 25 - 34
  • [46] Healthcare resource utilization and costs among patients with relapsed/refractory multiple myeloma treated with chimeric antigen receptor-T (CAR-T) cell therapy
    Jagannath, Sundar
    Kharat, Akshay
    Fu, Alex
    Huo, Stephen
    Kohli, Monal
    Adams, Shayna
    Umeh, Emeka
    Foster, Miran
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S187 - S188
  • [47] Healthcare Resource Utilization and Costs Among Patients With Relapsed/Refractory Multiple Myeloma Treated With Chimeric Antigen Receptor-T (CAR-T) Cell Therapy
    Jagannath, Sundar
    Kharat, Akshay
    Fu, Alex
    Huo, Stephen
    Kohli, Monal
    Adams, Shayna
    Umeh, Emeka
    Foster, Miran
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S511 - S512
  • [48] Current Status of CAR-T Cell Therapy in Multiple Myeloma
    Reguera-Ortega, Juan Luis
    Garcia-Guerrero, Estefania
    Perez-Simon, Jose Antonio
    HEMATO, 2021, 2 (04): : 660 - 671
  • [49] Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy
    Cheng, Hai
    Sun, Yingjun
    Zhang, Xiaoxue
    Chen, Zihan
    Shao, Lingyan
    Liu, Jiaying
    Wang, Dandan
    Chen, Yegan
    Wang, Xue
    Chen, Wei
    Sang, Wei
    Qi, Kunming
    Li, Zhenyu
    Sun, Cai
    Shi, Ming
    Qiao, Jianlin
    Wu, Qingyun
    Zeng, Lingyu
    Zheng, Junnian
    Xu, Kailin
    Cao, Jiang
    CYTOTHERAPY, 2024, 26 (08) : 832 - 841
  • [50] Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma
    Costa, Luciano J.
    Lin, Yi
    Cornell, R. Frank
    Martin, Thomas
    Chhabra, Saurabh
    Usmani, Saad Z.
    Jagannath, Sundar
    Callander, Natalie S.
    Berdeja, Jesus G.
    Kang, Yubin
    Vij, Ravi
    Godby, Kelly N.
    Malek, Ehsan
    Neppalli, Amarendra
    Liedtke, Michaela
    Fiala, Mark
    Tian, Hong
    Valluri, Satish
    Marino, Jennifer
    Jackson, Carolyn C.
    Banerjee, Arnob
    Kansagra, Ankit
    Schecter, Jordan M.
    Kumar, Shaji
    Hari, Parameswaran
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (05): : 326 - 335
12345